{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:14:22Z","timestamp":1790388862057,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T00:00:00Z","timestamp":1458345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T00:00:00Z","timestamp":1458345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"VA","award":["VA Merit Award\/I01BX001733"],"award-info":[{"award-number":["VA Merit Award\/I01BX001733"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 DK061010, U01 DK061034, U01 DK061042, U01 DK06"],"award-info":[{"award-number":["U01 DK061010, U01 DK061034, U01 DK061042, U01 DK06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008664","name":"Juvenile Diabetes Research Foundation","doi-asserted-by":"publisher","award":["SRA-2014-41"],"award-info":[{"award-number":["SRA-2014-41"]}],"id":[{"id":"10.13039\/100008664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00125-016-3924-5","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T01:50:31Z","timestamp":1458352231000},"page":"1186-1195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants"],"prefix":"10.1007","volume":"59","author":[{"name":"for the Type 1 Diabetes TrialNet Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah A.","family":"Meah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"DiMeglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla J.","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice S.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay M.","family":"Sosenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmella","family":"Evans-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,19]]},"reference":[{"key":"3924_CR1","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s001250051309","volume":"42","author":"P Onkamo","year":"1999","unstructured":"Onkamo P, Vaananen S, Karvonen M, Tuomilehto J (1999) Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends. Diabetologia 42:1395\u20131403","journal-title":"Diabetologia"},{"key":"3924_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1464-5491.2006.01925.x","volume":"23","author":"DIAMOND Project Group","year":"2006","unstructured":"DIAMOND Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 23:857\u2013866","journal-title":"Diabet Med"},{"key":"3924_CR3","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/S0140-6736(09)60568-7","volume":"373","author":"CC Patterson","year":"2009","unstructured":"Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373:2027\u20132033","journal-title":"Lancet"},{"key":"3924_CR4","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.2337\/db13-1891","volume":"63","author":"JM Lawrence","year":"2014","unstructured":"Lawrence JM, Imperatore G, Dabelea D et al (2014) Trends in incidence of type 1 diabetes among non-hispanic white youth in the United States, 2002-2009. Diabetes 63:3938\u20133945","journal-title":"Diabetes"},{"key":"3924_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00125-013-3153-0","volume":"57","author":"MY Donath","year":"2014","unstructured":"Donath MY, Hess C, Palmer E (2014) What is the role of autoimmunity in type 1 diabetes? A clinical perspective. Diabetologia 57:653\u2013655","journal-title":"Diabetologia"},{"key":"3924_CR6","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2337\/dc08-0239","volume":"31","author":"S Fourlanos","year":"2008","unstructured":"Fourlanos S, Varney MD, Tait BD et al (2008) The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31:1546\u20131549","journal-title":"Diabetes Care"},{"key":"3924_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s001250051626","volume":"44","author":"MJ Redondo","year":"2001","unstructured":"Redondo MJ, Yu L, Hawa M et al (2001) Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44:354\u2013362","journal-title":"Diabetologia"},{"key":"3924_CR8","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/bmj.304.6833.1020","volume":"304","author":"HJ Bodansky","year":"1992","unstructured":"Bodansky HJ, Staines A, Stephenson C, Haigh D, Cartwright R (1992) Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. Br Med J (Clin Res Ed) 304:1020\u20131022","journal-title":"Br Med J (Clin Res Ed)"},{"key":"3924_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMra020100","volume":"347","author":"JF Bach","year":"2002","unstructured":"Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911\u2013920","journal-title":"N Engl J Med"},{"key":"3924_CR10","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00125-014-3340-7","volume":"57","author":"DA Schneider","year":"2014","unstructured":"Schneider DA, von Herrath MG (2014) Potential viral pathogenic mechanism in human type 1 diabetes. Diabetologia 57:2009\u20132018","journal-title":"Diabetologia"},{"key":"3924_CR11","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.2337\/db08-0331","volume":"57","author":"O Vaarala","year":"2008","unstructured":"Vaarala O, Atkinson MA, Neu J (2008) The \u201cperfect storm\u201d for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57:2555\u20132562","journal-title":"Diabetes"},{"key":"3924_CR12","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","volume":"358","author":"E Hypponen","year":"2001","unstructured":"Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500\u20131503","journal-title":"Lancet"},{"key":"3924_CR13","first-page":"4782","volume":"86","author":"T Kimpimaki","year":"2001","unstructured":"Kimpimaki T, Kupila A, Hamalainen AM et al (2001) The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab 86:4782\u20134788","journal-title":"J Clin Endocrinol Metab"},{"key":"3924_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/jech.2011.133694","volume":"66","author":"SG Howard","year":"2012","unstructured":"Howard SG, Lee DH (2012) What is the role of human contamination by environmental chemicals in the development of type 1 diabetes? J Epidemiol Community Health 66:479\u2013481","journal-title":"J Epidemiol Community Health"},{"key":"3924_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1399-5448.2007.00343.x","volume":"9","author":"TJ Wilkin","year":"2008","unstructured":"Wilkin TJ (2008) Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis. Pediatr Diabetes 9:23\u201332","journal-title":"Pediatr Diabetes"},{"key":"3924_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF00428783","volume":"37","author":"C Johansson","year":"1994","unstructured":"Johansson C, Samuelsson U, Ludvigsson J (1994) A high weight gain early in life is associated with an increased risk of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 37:91\u201394","journal-title":"Diabetologia"},{"key":"3924_CR17","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s00125-005-0033-2","volume":"48","author":"I Knerr","year":"2005","unstructured":"Knerr I, Wolf J, Reinehr T et al (2005) The \u2018accelerator hypothesis\u2019: relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus. Diabetologia 48:2501\u20132504","journal-title":"Diabetologia"},{"key":"3924_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2337\/diacare.29.02.06.dc05-1339","volume":"29","author":"D Dabelea","year":"2006","unstructured":"Dabelea D, D\u2019Agostino RB Jr, Mayer-Davis EJ et al (2006) Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes. Diabetes Care 29:290\u2013294","journal-title":"Diabetes Care"},{"key":"3924_CR19","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.2337\/diacare.26.10.2865","volume":"26","author":"M Kibirige","year":"2003","unstructured":"Kibirige M, Metcalf B, Renuka R, Wilkin TJ (2003) Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care 26:2865\u20132870","journal-title":"Diabetes Care"},{"key":"3924_CR20","unstructured":"Fryar CD CM, Ogden CL (2012) Prevalence of Obesity Among Children and Adolescents: United States, Trends 1963\u20131965 Through 2009\u20132010. Available from \n                    http:\/\/www.cdc.gov\/nchs\/data\/hestat\/obesity_child_09_10\/obesity_child_09_10.pdf\n                    \n                  , accessed 29 Mar 2014."},{"key":"3924_CR21","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.2337\/dc06-2389","volume":"30","author":"P Xu","year":"2007","unstructured":"Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP (2007) Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 30:2314\u20132320","journal-title":"Diabetes Care"},{"key":"3924_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1067\/mpd.2001.111274","volume":"138","author":"HP Chase","year":"2001","unstructured":"Chase HP, Cuthbertson DD, Dolan LM et al (2001) First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr 138:244\u2013249","journal-title":"J Pediatr"},{"key":"3924_CR23","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2337\/dc11-0641","volume":"34","author":"JM Sosenko","year":"2011","unstructured":"Sosenko JM, Skyler JS, Mahon J et al (2011) Validation of the Diabetes Prevention Trial-type 1 risk score in the TrialNet Natural History Study. Diabetes Care 34:1785\u20131787","journal-title":"Diabetes Care"},{"key":"3924_CR24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2337\/dc13-2359","volume":"37","author":"JM Sosenko","year":"2014","unstructured":"Sosenko JM, Skyler JS, Mahon J et al (2014) Use of the Diabetes Prevention Trial-type 1 risk score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes. Diabetes Care 37:979\u2013984","journal-title":"Diabetes Care"},{"key":"3924_CR25","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.2337\/dc12-0011","volume":"35","author":"JM Sosenko","year":"2012","unstructured":"Sosenko JM, Skyler JS, Mahon J et al (2012) The application of the Diabetes Prevention Trial-type 1 risk score for identifying a preclinical state of type 1 diabetes. Diabetes Care 35:1552\u20131555","journal-title":"Diabetes Care"},{"key":"3924_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1196\/annals.1447.054","volume":"1150","author":"JS Skyler","year":"2008","unstructured":"Skyler JS, Greenbaum CJ, Lachin JM et al (2008) Type 1 Diabetes TrialNet--an international collaborative clinical trials network. Ann N Y Acad Sci 1150:14\u201324","journal-title":"Ann N Y Acad Sci"},{"key":"3924_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1399-5448.2008.00464.x","volume":"10","author":"JL Mahon","year":"2009","unstructured":"Mahon JL, Sosenko JM, Rafkin-Mervis L et al (2009) The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes 10:97\u2013104","journal-title":"Pediatr Diabetes"},{"key":"3924_CR28","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2337\/dc11-2081","volume":"35","author":"L Yu","year":"2012","unstructured":"Yu L, Boulware DC, Beam CA et al (2012) Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care 35:1213\u20131218","journal-title":"Diabetes Care"},{"key":"3924_CR29","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.2337\/dc07-2451","volume":"31","author":"CJ Greenbaum","year":"2008","unstructured":"Greenbaum CJ, Mandrup-Poulsen T, McGee PF et al (2008) Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31:1966\u20131971","journal-title":"Diabetes Care"},{"key":"3924_CR30","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2337\/dc11-0560","volume":"34","author":"K Vehik","year":"2011","unstructured":"Vehik K, Beam CA, Mahon JL et al (2011) Development of autoantibodies in the TrialNet Natural History Study. Diabetes Care 34:1897\u20131901","journal-title":"Diabetes Care"},{"key":"3924_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1399-5448.2010.00662.x","volume":"12","author":"JM Sosenko","year":"2011","unstructured":"Sosenko JM, Mahon J, Rafkin L et al (2011) A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants. Pediatr Diabetes 12:85\u201390","journal-title":"Pediatr Diabetes"},{"key":"3924_CR32","doi-asserted-by":"crossref","unstructured":"(2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685\u20131691","DOI":"10.1056\/NEJMoa012350"},{"key":"3924_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1542\/peds.109.1.45","volume":"109","author":"CL Ogden","year":"2002","unstructured":"Ogden CL, Kuczmarski RJ, Flegal KM et al (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45\u201360","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"3924_CR34","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc14-S014","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association (2014) Standards of medical care in diabetes--2014. Diabetes Care 37(Suppl 1):S14\u2013S80","journal-title":"Diabetes Care"},{"key":"3924_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","volume":"80","author":"DY Lin","year":"1993","unstructured":"Lin DY, Wei LJ, Ying Z (1993) Checking the Cox model with cumulative sums of Martingale-based residuals. Biometrika 80:557\u2013572","journal-title":"Biometrika"},{"key":"3924_CR36","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/db07-1331","volume":"57","author":"H Erlich","year":"2008","unstructured":"Erlich H, Valdes AM, Noble J et al (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57:1084\u20131092","journal-title":"Diabetes"},{"key":"3924_CR37","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2337\/db10-1419","volume":"60","author":"AK Steck","year":"2011","unstructured":"Steck AK, Armstrong TK, Babu SR, Eisenbarth GS (2011) Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years. Diabetes 60:1045\u20131049","journal-title":"Diabetes"},{"key":"3924_CR38","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jama.2014.732","volume":"311","author":"CL Ogden","year":"2014","unstructured":"Ogden CL, Carroll MD, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311:806\u2013814","journal-title":"JAMA"},{"key":"3924_CR39","doi-asserted-by":"crossref","unstructured":"(2000) Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet 355:873\u2013876","DOI":"10.1016\/S0140-6736(99)07125-1"},{"key":"3924_CR40","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1007\/s00125-009-1461-1","volume":"52","author":"C Winkler","year":"2009","unstructured":"Winkler C, Marienfeld S, Zwilling M, Bonifacio E, Ziegler AG (2009) Is islet autoimmunity related to insulin sensitivity or body weight in children of parents with type 1 diabetes? Diabetologia 52:2072\u20132078","journal-title":"Diabetologia"},{"key":"3924_CR41","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1007\/s00125-009-1428-2","volume":"52","author":"MM Lamb","year":"2009","unstructured":"Lamb MM, Yin X, Zerbe GO et al (2009) Height growth velocity, islet autoimmunity and type 1 diabetes development: the Diabetes Autoimmunity Study in the Young. Diabetologia 52:2064\u20132071","journal-title":"Diabetologia"},{"key":"3924_CR42","doi-asserted-by":"publisher","first-page":"E82","DOI":"10.1210\/jc.2014-2340","volume":"100","author":"M Cedillo","year":"2015","unstructured":"Cedillo M, Libman IM, Arena VC et al (2015) Obesity, islet cell autoimmunity, and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes. J Clin Endocrinol Metab 100:E82\u2013E86","journal-title":"J Clin Endocrinol Metab"},{"key":"3924_CR43","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2337\/dc12-0767","volume":"36","author":"TH Lipman","year":"2013","unstructured":"Lipman TH, Levitt Katz LE, Ratcliffe SJ et al (2013) Increasing incidence of type 1 diabetes in youth: twenty years of the Philadelphia Pediatric Diabetes Registry. Diabetes Care 36:1597\u20131603","journal-title":"Diabetes Care"},{"key":"3924_CR44","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dc06-2578","volume":"30","author":"M Gimenez","year":"2007","unstructured":"Gimenez M, Aguilera E, Castell C, de Lara N, Nicolau J, Conget I (2007) Relationship between BMI and age at diagnosis of type 1 diabetes in a Mediterranean area in the period of 1990-2004. Diabetes Care 30:1593\u20131595","journal-title":"Diabetes Care"},{"key":"3924_CR45","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1464-5491.2007.02203.x","volume":"24","author":"MA O\u2019Connell","year":"2007","unstructured":"O\u2019Connell MA, Donath S, Cameron FJ (2007) Major increase in type 1 diabetes: no support for the accelerator hypothesis. Diabet Med 24:920\u2013923","journal-title":"Diabet Med"},{"key":"3924_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2337\/dc08-0821","volume":"32","author":"JJ Couper","year":"2009","unstructured":"Couper JJ, Beresford S, Hirte C et al (2009) Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes. Diabetes Care 32:94\u201399","journal-title":"Diabetes Care"},{"key":"3924_CR47","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.381","volume":"41","author":"JC Barrett","year":"2009","unstructured":"Barrett JC, Clayton DG, Concannon P et al (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41:703\u2013707","journal-title":"Nat Genet"},{"key":"3924_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/pedi.12092","volume":"15","author":"AK Steck","year":"2014","unstructured":"Steck AK, Dong F, Wong R et al (2014) Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers. Pediatr Diabetes 15:355\u2013362","journal-title":"Pediatr Diabetes"},{"key":"3924_CR49","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/diacare.27.6.1399","volume":"27","author":"JM Barker","year":"2004","unstructured":"Barker JM, Goehrig SH, Barriga K et al (2004) Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 27:1399\u20131404","journal-title":"Diabetes Care"},{"key":"3924_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1399-5448.2011.00763.x","volume":"13","author":"AG Ziegler","year":"2012","unstructured":"Ziegler AG, Meier-Stiegen F, Winkler C, Bonifacio E (2012) Prospective evaluation of risk factors for the development of islet autoimmunity and type 1 diabetes during puberty--TEENDIAB: study design. Pediatr Diabetes 13:419\u2013424","journal-title":"Pediatr Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-3924-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-016-3924-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-3924-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-3924-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:25:42Z","timestamp":1589549142000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-016-3924-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,19]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3924"],"URL":"https:\/\/doi.org\/10.1007\/s00125-016-3924-5","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,19]]},"assertion":[{"value":"21 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The sponsor of the trial was the Type 1 Diabetes TrialNet Pathway to Prevention Study Group. Type 1 Diabetes TrialNet Pathway to Prevention Study Group is a clinical trials network funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, and The Eunice Kennedy Shriver National Institute of Child Health and Human Development, through the cooperative agreements U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085465, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085504, U01 DK085505, U01 DK085509, U01 DK103180, U01-DK103153, U01-DK085476, U01-DK103266 and the Juvenile Diabetes Research Foundation International (JDRF). This work was also partially supported by NIH grants R01 DK093954 and UC4 DK 104166 (to CEM), VA Merit Award I01BX001733 (to CEM) and JDRF grant SRA-2014-41 (to CEM, LAD and JSB). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, the US Department of Veterans Affairs or the United States Government, the JDRF or American Diabetes Association.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"FAM, CEM, PX and SG conceptualised the analysis, analysed and interpreted data, and wrote the manuscript. LAD, CJG, JSB, JMS and AP conceptualised the analysis, interpreted data and reviewed\/edited the manuscript. CEM is the guarantor of this work, and all authors provided final approval of the manuscript prior to publishing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}